-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LSMEPBX0IhbQ8c3Kii0wWhY1MzeTW8xNmyh0xtLSBc4tjabbBb6VHdsLtsVbv2hH Ohc9EPjgvPN/wmzv/D/2MA== 0000912057-02-026525.txt : 20020703 0000912057-02-026525.hdr.sgml : 20020703 20020703172757 ACCESSION NUMBER: 0000912057-02-026525 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020703 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SYNSORB BIOTECH INC CENTRAL INDEX KEY: 0001025863 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-52837 FILM NUMBER: 02696840 BUSINESS ADDRESS: STREET 1: STE 410 STREET 2: 1167 KENINGTON CRESCENT NW CITY: CALGARY ALBERTA CANA STATE: A0 ZIP: T2N 1X7 BUSINESS PHONE: 4032835900 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCOUT CAPITAL CORP CENTRAL INDEX KEY: 0001164046 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 400,521 3RD AVE SW STREET 2: T2P 3T3 CITY: CALGARY STATE: A0 ZIP: 00000 BUSINESS PHONE: 4032633653 MAIL ADDRESS: STREET 1: 400,521 3RD AVE SW STREET 2: T2P 3T3 CITY: CALGARY STATE: A0 ZIP: 00000 SC 13D/A 1 a2083966zsc13da.txt SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 6) SYNSORB BIOTECH INC. (Name of Issuer) COMMON STOCK, NO PAR VALUE (Title of Class of Securities) 87160V-10-4 (CUSIP Number) GREGORY B. MATTHEWS 400,521-3RD AVENUE S.W. CALGARY, ALBERTA T2P 3T3 (403) 263-3653 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) COPY TO: WILLIAM L. BOEING HAYNES AND BOONE, LLP 1600 N. COLLINS BLVD., SUITE 2000 RICHARDSON, TEXAS 75080 (972) 680-7553 JUNE 10, 2002 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box: / / SCHEDULE 13D CUSIP No. 87160V-10-4 (1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Scout Capital Corp. (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) /X/ (3) SEC USE ONLY (4) SOURCE OF FUNDS WC (5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) / / (6) CITIZENSHIP OR PLACE OF ORGANIZATION Alberta, Canada (7) SOLE VOTING POWER NUMBER OF 676,002 SHARES BENEFICIALLY (8) SHARED VOTING POWER OWNED BY 0 EACH REPORTING (9) SOLE DISPOSITIVE POWER PERSON WITH 676,002 (10) SHARED DISPOSITIVE POWER 0 (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 676,002 (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13.6% (14) TYPE OF REPORTING PERSON CO This Amendment No. 6 to Schedule 13D (this 'Amendment') amends and supplements the Schedule 13D filed by Scout Capital Corp. with the Securities and Exchange Commission ('SEC') on December 31, 2001 relating to the Common Stock of Synsorb Biotech Inc., as amended by Amendment No. 1 to Schedule 13D filed with the SEC on January 8, 2002, Amendment No. 2 to Schedule 13D filed with the SEC on April 23, 2002, Amendment No. 3 to Schedule 13D filed with the SEC on April 25, 2002, Amendment No. 4 to Schedule 13D filed with the SEC on May, 23, 2002 and Amendment No. 5 to Schedule 13D filed with the SEC on May 31, 2002 (as previously amended, the 'Filing'). Capitalized terms used herein which are not defined herein have the meanings given to them in the Filing. The main purpose of this amendment is to amend and restate the information contained in Item 5 of the Filing. Except as set forth below, all previous Items of the Filing remain unchanged. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. Item 5 is hereby amended in its entirety to read as follows: SCOUT CAPITAL CORP. (a) Number of Securities Beneficially Owned: 676,002 shares of Common Stock Percentage of Class: 13.6% (b) Sole Voting Power: 676,002 shares of Common Stock Shared Voting Power: 0 shares of Common Stock Sole Dispositive Power: 676,002 shares of Common Stock Shared Dispositive Power: 0 shares of Common Stock (c) The transactions made by Scout in the Common Stock since the date of the last amendment to the Filing are detailed on Schedule A hereto, which is incorporated herein by this reference. JIM SILYE (a) Number of Securities Beneficially Owned: 12,750 shares of Common Stock Percentage of Class: 0.3% (b) Sole Voting Power: 12,750 shares of Common Stock Shared Voting Power: 0 shares of Common Stock Sole Dispositive Power: 12,750 shares of Common Stock Shared Dispositive Power: 0 shares of Common Stock (c) Mr. Silye has not purchased Common Stock since the date of the last amendment to the Filing. SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this Amendment is true, complete and correct. SCOUT CAPITAL CORP. By: /s/ David L. Tonken ----------------------------- Name: David L. Tonken Title: Chief Executive Officer Date: July 3, 2002 SCHEDULE A SCOUT TRANSACTIONS IN THE COMMON STOCK TRADES EXECUTED ON THE TORONTO STOCK EXCHANGE:
DATE NUMBER OF SHARES PRICE (CDN.) 1. June 10, 2002 52,400 $1.2292 2. June 11, 2002 38,300 $1.2397 3. June 21, 2002 47,500 $1.2982 4. June 28, 2002 23,100 $1.3649
-----END PRIVACY-ENHANCED MESSAGE-----